CA
SUPN icon

Clearstead Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Clearstead Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$373 Buy
+8
New +$384 ﹤0.01% 3016
2025
Q4 		– Sell
-21
Closed -$1K – 3218
2025
Q3 		$1K Buy
+21
New +$846 ﹤0.01% 2619
2021
Q4 		– Sell
-626
Closed -$17K – 1430
2021
Q3 		$17K Buy
+626
New +$16.8K ﹤0.01% 864
2021
Q2 		– Sell
-100
Closed -$3K – 1300
2021
Q1 		$3K Buy
+100
New +$2.8K ﹤0.01% 938

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Clearstead Advisors's SUPN Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Supernus Pharmaceuticals (SUPN) in Q2 2026: 8 shares worth $373. The stake represents ﹤0.01% of the portfolio and ranks #3016 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in SUPN as recently as Q3 2025.

Clearstead Advisors first reported a position in SUPN in Q1 2021 and has held it in 4 quarters since. The position peaked at $17K in Q3 2021. 131 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Clearstead Advisors held 8 shares of Supernus Pharmaceuticals worth $373 as of Q2 2026.
  • Supernus Pharmaceuticals was a new Clearstead Advisors position in Q2 2026.
  • Supernus Pharmaceuticals made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3016 holding.
  • Clearstead Advisors first reported a position in Supernus Pharmaceuticals in Q1 2021 and has held it in 4 quarters since.
  • Clearstead Advisors's Supernus Pharmaceuticals position peaked at $17K in Q3 2021.
  • 131 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.